Skip to main content
Erschienen in: Archives of Virology 12/2017

07.09.2017 | Brief Report

Identification of a serotype-independent linear epitope of foot-and-mouth disease virus

verfasst von: Baolin Yang, Mingxia Wang, Wenming Liu, Zhiqiang Xu, Haiwei Wang, Decheng Yang, Wenge Ma, Guohui Zhou, Li Yu

Erschienen in: Archives of Virology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Foot-and-mouth disease (FMD), caused by foot-and-mouth disease virus (FMDV), is a highly contagious infectious disease that affects domestic and wild cloven-hoofed animals worldwide. VP2 is a structural protein of FMDV. In this study, an FMDV serotype-independent monoclonal antibody (MAb), 10B10, against the viral capsid protein VP2 was generated, and a series of GST fusion proteins expressing a truncated peptide of VP2 was subjected to Western blot analysis using MAb 10B10. Their results indicated that the peptide 8TLLEDRILT16 of VP2 is the minimal requirement of the epitope recognized by MAb 10B10. Importantly, this linear epitope was highly conserved among all seven serotypes of FMDV in a sequence alignment analysis. Subsequent alanine-scanning mutagenesis analysis revealed that the residues Thr8 and Asp12 of the epitope were crucial for MAb-10B10 binding. Furthermore, Western blot analysis also revealed that the MAb 10B10-directed epitope could be recognized by positive sera from FMDV-infected cattle. The discovery that MAb 10B10 recognizes a serotype-independent linear epitope of FMDV suggests potential applications for this MAb in the development of serotype-independent tests for FMDV.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Barteling SJ (2002) Development and performance of inactivated vaccines against foot and mouth disease. Rev Sci Tech 21(3):577–588CrossRefPubMed Barteling SJ (2002) Development and performance of inactivated vaccines against foot and mouth disease. Rev Sci Tech 21(3):577–588CrossRefPubMed
3.
Zurück zum Zitat Curry S, Fry E, Blakemore W, Abughazaleh R, Jackson T, King A, Lea S, Newman J, Stuart D (1997) Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71:9743–9752PubMedPubMedCentral Curry S, Fry E, Blakemore W, Abughazaleh R, Jackson T, King A, Lea S, Newman J, Stuart D (1997) Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71:9743–9752PubMedPubMedCentral
4.
Zurück zum Zitat Denisova GF, Denisov DA, Yeung J, Loeb MB, Diamond MS, Bramson JL (2008) A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: a case study using monoclonal antibodies against the West Nile virus E protein. Mol immunol 46(1):125–134CrossRefPubMed Denisova GF, Denisov DA, Yeung J, Loeb MB, Diamond MS, Bramson JL (2008) A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: a case study using monoclonal antibodies against the West Nile virus E protein. Mol immunol 46(1):125–134CrossRefPubMed
6.
Zurück zum Zitat Freiberg B, Höhlich B, Haas B, Saalmüller A, Pfaff E, Marquardt O (2001) Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. J Virol Methods 92(2):199–205CrossRefPubMed Freiberg B, Höhlich B, Haas B, Saalmüller A, Pfaff E, Marquardt O (2001) Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. J Virol Methods 92(2):199–205CrossRefPubMed
8.
Zurück zum Zitat Levy R, Forsyth CM, LaPorte SL, Geren IN, Smith LA, Marks JD (2007) Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J Mol Biol 365(1):196–210CrossRefPubMed Levy R, Forsyth CM, LaPorte SL, Geren IN, Smith LA, Marks JD (2007) Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J Mol Biol 365(1):196–210CrossRefPubMed
9.
Zurück zum Zitat Liang W, Zhou G, Liu W, Yang B, Li C, Wang H, Yang D, Ma W, Yu L (2016) Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus. Arch Virol 161:2705–2716CrossRefPubMed Liang W, Zhou G, Liu W, Yang B, Li C, Wang H, Yang D, Ma W, Yu L (2016) Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus. Arch Virol 161:2705–2716CrossRefPubMed
10.
Zurück zum Zitat Liu W, Yang B, Wang M, Liang W, Wang H, Yang D, Ma W, Zhou G, Yu L (2017) Identification of a conserved conformational epitope in the VP2 protein of foot-and-mouth disease virus. Arch Virol 162:1877–1885CrossRefPubMed Liu W, Yang B, Wang M, Liang W, Wang H, Yang D, Ma W, Zhou G, Yu L (2017) Identification of a conserved conformational epitope in the VP2 protein of foot-and-mouth disease virus. Arch Virol 162:1877–1885CrossRefPubMed
11.
Zurück zum Zitat May C, Doody JF, Abdullah R, Balderes P, Xu X, Chen CP, Zhu Z, Shapiro L, Kussie P, Hicklin DJ, Liao F, Bohlen P (2005) Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 105(11):4337–4344CrossRefPubMed May C, Doody JF, Abdullah R, Balderes P, Xu X, Chen CP, Zhu Z, Shapiro L, Kussie P, Hicklin DJ, Liao F, Bohlen P (2005) Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 105(11):4337–4344CrossRefPubMed
12.
Zurück zum Zitat Pereira HG (1981) Foot-and-mouth disease. Academic Press Inc., London Pereira HG (1981) Foot-and-mouth disease. Academic Press Inc., London
13.
Zurück zum Zitat Saiz JC, Gonzalez MJ, Borca MV, Sobrino F, Moore DM (1991) Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol 65(5):2518–2524PubMedPubMedCentral Saiz JC, Gonzalez MJ, Borca MV, Sobrino F, Moore DM (1991) Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol 65(5):2518–2524PubMedPubMedCentral
14.
Zurück zum Zitat Shen X, Parks RJ, Montefiori DC, Kirchherr JL, Keele BF, Decker JM, Blattner WA, Gao F, Weinhold KJ, Hicks CB, Greenberg ML, Hahn BH, Shaw GM, Haynes BF, Tomaras GD (2009) In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J Virol 83(8):3617–3625CrossRefPubMedPubMedCentral Shen X, Parks RJ, Montefiori DC, Kirchherr JL, Keele BF, Decker JM, Blattner WA, Gao F, Weinhold KJ, Hicks CB, Greenberg ML, Hahn BH, Shaw GM, Haynes BF, Tomaras GD (2009) In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J Virol 83(8):3617–3625CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, Williams KL, Johnson S, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS (2010) Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol 84(18):9227–9239CrossRefPubMedPubMedCentral Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, Williams KL, Johnson S, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS (2010) Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol 84(18):9227–9239CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Yang M, Clavijo A, Suarez-Banmann R, Avalo R (2007) Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Vet Immunol Immunopathol 115:126–134CrossRefPubMed Yang M, Clavijo A, Suarez-Banmann R, Avalo R (2007) Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Vet Immunol Immunopathol 115:126–134CrossRefPubMed
17.
Zurück zum Zitat Yang M, Goolia M, Xu W, Bittner H, Clavijo A (2013) Development of a quick and simple detection methodology for foot-and-mouth disease virus serotypes O, A and Asia 1 using a generic RapidAssay Device. Virol J 10:125CrossRefPubMedPubMedCentral Yang M, Goolia M, Xu W, Bittner H, Clavijo A (2013) Development of a quick and simple detection methodology for foot-and-mouth disease virus serotypes O, A and Asia 1 using a generic RapidAssay Device. Virol J 10:125CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Yu Y, Wang H, Zhao L, Zhang C, Jiang Z, Li Y (2011) Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2. J Microbiol 49:94–101CrossRefPubMed Yu Y, Wang H, Zhao L, Zhang C, Jiang Z, Li Y (2011) Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2. J Microbiol 49:94–101CrossRefPubMed
19.
Zurück zum Zitat Zheng H, Lian K, Yang F, Jin Y, Zhu Z, Guo J, Cao W, Liu H, He J, Zhang K, Li D, Liu X (2015) Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine. Vaccine 33:5772–5778CrossRefPubMed Zheng H, Lian K, Yang F, Jin Y, Zhu Z, Guo J, Cao W, Liu H, He J, Zhang K, Li D, Liu X (2015) Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine. Vaccine 33:5772–5778CrossRefPubMed
Metadaten
Titel
Identification of a serotype-independent linear epitope of foot-and-mouth disease virus
verfasst von
Baolin Yang
Mingxia Wang
Wenming Liu
Zhiqiang Xu
Haiwei Wang
Decheng Yang
Wenge Ma
Guohui Zhou
Li Yu
Publikationsdatum
07.09.2017
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 12/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3544-5

Weitere Artikel der Ausgabe 12/2017

Archives of Virology 12/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.